Pharma Suits Still Low Despite ITC Surge

Law360, New York (August 1, 2008, 12:00 AM EDT) -- Though litigation before the U.S. International Trade Commission is surging, the pharmaceutical sector still accounts for a relatively small portion of the cases on the ITC docket. But that could change as pharmaceutical industries in emerging markets like China gain momentum, some lawyers say.

Many of the same petitioners seeking redress before the ITC are involved in patent suits before district courts, such as telecommunications and electronics companies, said Arthur Wineburg, a Washington, D.C.-based partner with Akin Gump Strauss Hauer & Feld LLP, who served as...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.